Page last updated: 2024-10-24

cetyltrimethylammonium ion and Hypoglycemia

cetyltrimethylammonium ion has been researched along with Hypoglycemia in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miki, R1
Takei, C1
Ohtani, Y1
Kawashima, K1
Yoshida, A1
Kojima, Y1
Egawa, Y1
Seki, T1
Iohara, D1
Anraku, M1
Hirayama, F1
Uekama, K1

Other Studies

1 other study available for cetyltrimethylammonium ion and Hypoglycemia

ArticleYear
Glucose Responsive Rheological Change and Drug Release from a Novel Worm-like Micelle Gel Formed in Cetyltrimethylammonium Bromide/Phenylboronic Acid/Water System.
    Molecular pharmaceutics, 2018, 03-05, Volume: 15, Issue:3

    Topics: Blood Glucose; Boronic Acids; Cetrimonium; Dextrans; Drug Delivery Systems; Drug Liberation; Fluores

2018